Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

When to use stem cell transplant in mantle cell lymphoma.

Greenwell IB, Cohen JB.

Expert Rev Hematol. 2019 Mar 7:1-4. doi: 10.1080/17474086.2019.1588106. [Epub ahead of print] No abstract available.

PMID:
30843742
2.
3.

The role of hematopoietic stem cell transplantation in non-Hodgkin lymphoma.

Villanueva ML, Vose JM.

Clin Adv Hematol Oncol. 2006 Jul;4(7):521-30. Review.

PMID:
17147239
4.

Phase I/II study of bortezomib-BEAM and autologous hematopoietic stem cell transplantation for relapsed indolent non-Hodgkin lymphoma, transformed, or mantle cell lymphoma.

William BM, Allen MS, Loberiza FR Jr, Bociek RG, Bierman PJ, Armitage JO, Vose JM.

Biol Blood Marrow Transplant. 2014 Apr;20(4):536-42. doi: 10.1016/j.bbmt.2014.01.004. Epub 2014 Jan 14.

5.

Autologous Stem Cell Transplant: Still the Standard for Fit Patients With Mantle Cell Lymphoma.

Staton AD, Langston AA.

Clin Lymphoma Myeloma Leuk. 2017 Jul;17S:S96-S99. doi: 10.1016/j.clml.2017.02.021.

PMID:
28760309
6.

Hematopoietic stem cell transplantation for non-Hodgkin lymphoma.

Bhatt VR, Vose JM.

Hematol Oncol Clin North Am. 2014 Dec;28(6):1073-95. doi: 10.1016/j.hoc.2014.08.015. Epub 2014 Sep 22. Review.

PMID:
25459180
7.

Bone marrow transplantation for lymphoma CR1.

Tarella C, Gianni AM.

Curr Opin Oncol. 2005 Mar;17(2):99-105. Review.

PMID:
15725912
8.

A Review of Autologous Stem Cell Transplantation in Lymphoma.

Zahid U, Akbar F, Amaraneni A, Husnain M, Chan O, Riaz IB, McBride A, Iftikhar A, Anwer F.

Curr Hematol Malig Rep. 2017 Jun;12(3):217-226. doi: 10.1007/s11899-017-0382-1. Review.

9.

The place of transplantation in mantle cell lymphoma.

Lunning MA, Armitage JO.

Oncology (Williston Park). 2013 Oct;27 Suppl 2:2-6. Review.

PMID:
25374998
10.

Immunotherapy with rituximab following high-dose therapy and autologous stem-cell transplantation for mantle cell lymphoma.

Mangel J, Buckstein R, Imrie K, Spaner D, Crump M, Tompkins K, Reis M, Perez-Ordonez B, Deodhare S, Romans R, Pennell N, Robinson JB, Hewitt K, Richardson P, Lima A, Pavlin P, Berinstein NL.

Semin Oncol. 2002 Feb;29(1 Suppl 2):56-69. Review.

PMID:
11842390
11.

Efficacy of Pharmacokinetics-Directed Busulfan, Cyclophosphamide, and Etoposide Conditioning and Autologous Stem Cell Transplantation for Lymphoma: Comparison of a Multicenter Phase II Study and CIBMTR Outcomes.

Flowers CR, Costa LJ, Pasquini MC, Le-Rademacher J, Lill M, Shore TB, Vaughan W, Craig M, Freytes CO, Shea TC, Horwitz ME, Fay JW, Mineishi S, Rondelli D, Mason J, Braunschweig I, Ai W, Yeh RF, Rodriguez TE, Flinn I, Comeau T, Yeager AM, Pulsipher MA, Bence-Bruckler I, Laneuville P, Bierman P, Chen AI, Kato K, Wang Y, Xu C, Smith AJ, Waller EK.

Biol Blood Marrow Transplant. 2016 Jul;22(7):1197-1205. doi: 10.1016/j.bbmt.2016.03.018. Epub 2016 Mar 31.

12.

Rituximab for aggressive non-Hodgkin's lymphomas relapsing after or refractory to autologous stem cell transplantation.

Pan D, Moskowitz CH, Zelenetz AD, Straus D, Kewalaramani T, Noy A, Qin J, Teruya-Feldstein J, Portlock CS.

Cancer J. 2002 Sep-Oct;8(5):371-6.

PMID:
12416894
13.

Prognosis and outcome of stem cell transplantation for mantle cell lymphoma.

Cheminant M, Robinson S, Ribrag V, Le Gouill S, Suarez F, Delarue R, Hermine O.

Expert Rev Hematol. 2015 Aug;8(4):493-504. doi: 10.1586/17474086.2015.1047759. Epub 2015 Jun 19. Review.

PMID:
26091558
14.

Allogeneic Stem Cell Transplantation for Non-Hodgkin Lymphoma.

Bhatt VR.

Curr Hematol Malig Rep. 2016 Jun;11(3):196-207. doi: 10.1007/s11899-016-0319-0. Review.

PMID:
26983957
15.

Improving outcomes in transplantation.

Brugger W.

Semin Oncol. 2002 Apr;29(2 Suppl 6):23-6. Review.

PMID:
12040531
16.

Autologous stem cell transplantation (ASCT) in patients with mantle cell lymphoma: a retrospective study of the Spanish lymphoma group (GELTAMO).

García-Noblejas A, Cannata-Ortiz J, Conde E, González Barca E, Gutiérrez N, Rojas R, Vidal MJ, Ramírez MJ, Jiménez-Ubieto A, García-Ruiz JC, Sancho JM, López A, Ríos Rull P, Novelli S, Albo C, Debén G, López-Guillermo A, Nicolás C, González de Villambrosia S, Mercadal S, Martín García-Sancho A, Arranz R.

Ann Hematol. 2017 Aug;96(8):1323-1330. doi: 10.1007/s00277-017-2998-6. Epub 2017 May 24.

PMID:
28536895
17.

Allogeneic stem cell transplantation for mantle cell lymphoma--does it deserve a better look?

Rifkind J, Mollee P, Messner HA, Lipton JH.

Leuk Lymphoma. 2005 Feb;46(2):217-23.

PMID:
15621804
18.

[Mantle Cell Lymphoma -  Cutting edge Dia-gnostics and Treatment Approaches].

Klener P Jr, Trněný M.

Klin Onkol. 2015;28 Suppl 3:3S80-6. Review. Czech.

PMID:
26489506
19.

Pseudo-autologous stem cell transplantation for donor-derived mantle cell lymphoma 12 years after allogeneic transplantation.

Tamaki M, Wada H, Gomyo A, Hayakawa J, Akahoshi Y, Harada N, Kusuda M, Ishihara Y, Kawamura K, Tanihara A, Sato M, Terasako-Saito K, Kameda K, Kikuchi M, Kimura SI, Nakasone H, Kako S, Kanda Y.

Int J Hematol. 2018 Jan;107(1):117-121. doi: 10.1007/s12185-017-2296-z. Epub 2017 Jul 6.

PMID:
28685308
20.

Outcomes of autologous and allogeneic blood or marrow transplantation for mantle cell lymphoma.

Kasamon YL, Jones RJ, Diehl LF, Nayer H, Borowitz MJ, Garrett-Mayer E, Ambinder RF, Abrams RA, Zhang Z, Flinn IW.

Biol Blood Marrow Transplant. 2005 Jan;11(1):39-46.

Supplemental Content

Support Center